Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Riemer

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Biological Chemistry|October 11, 2001
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)V Magdolen, M Bürgle, N A de Prada, et al.
Endocrine-Related Cancer|January 11, 2018
IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancerThomas A Werner, Inga Nolten, Levent Dizdar, et al.
Biological Chemistry|March 1, 1997
Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptidesM Bürgle, M Koppitz, C Riemer, et al.
Cellular Immunology|May 8, 2012
Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupusMohammed M Al Gadban, Jashalynn German, Jean-Philip Truman, et al.
Scientific Reports|September 14, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinomaThomas A Werner, Levent Dizdar, Inga Nolten, et al.
Nucleic Acids Research|March 10, 2001
Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5M D Wilson, C Riemer, D W Martindale, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 17, 2015
Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcomaSabrina Mersch, Jasmin C Riemer, Philipp M Schlünder, et al.
Oncotarget|January 1, 2017
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasiaLevent Dizdar, Kira A Oesterwind, Jasmin C Riemer, et al.
Cold Spring Harbor Symposia on Quantitative Biology|September 2, 2004
Global predictions and tests of erythroid regulatory regionsR C Hardison, F Chiaromonte, D Kolbe, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Biological Chemistry|October 11, 2001
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)V Magdolen, M Bürgle, N A de Prada, et al.
Endocrine-Related Cancer|January 11, 2018
IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancerThomas A Werner, Inga Nolten, Levent Dizdar, et al.
Biological Chemistry|March 1, 1997
Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptidesM Bürgle, M Koppitz, C Riemer, et al.
Cellular Immunology|May 8, 2012
Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupusMohammed M Al Gadban, Jashalynn German, Jean-Philip Truman, et al.
Scientific Reports|September 14, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinomaThomas A Werner, Levent Dizdar, Inga Nolten, et al.
Nucleic Acids Research|March 10, 2001
Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5M D Wilson, C Riemer, D W Martindale, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 17, 2015
Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcomaSabrina Mersch, Jasmin C Riemer, Philipp M Schlünder, et al.
Oncotarget|January 1, 2017
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasiaLevent Dizdar, Kira A Oesterwind, Jasmin C Riemer, et al.
Cold Spring Harbor Symposia on Quantitative Biology|September 2, 2004
Global predictions and tests of erythroid regulatory regionsR C Hardison, F Chiaromonte, D Kolbe, et al.
Pageof 6